Sekse Ragnhild Johanne Tveit, Hufthammer Karl Ove, Vika Margrethe Elin
Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
J Clin Nurs. 2015 Feb;24(3-4):546-55. doi: 10.1111/jocn.12647. Epub 2014 Jul 12.
To examine the prevalence of cancer-related fatigue in women treated for various types of gynaecological cancers and, for these cancers, to assess fatigue in relation to distress, health-related quality of life, demography and treatment characteristics.
Advances in treatment of cancer have improved the likelihood of survival. Consequently, there are a growing number of patients who become survivors after cancer and who face side effects even years after treatment. One of the most frequently reported side effects across all types and stages of the disease is cancer-related fatigue.
A descriptive cross-sectional study.
One hundred and twenty women treated for gynaecological cancers who were participants in an intervention study were included. Fatigue, psychological distress, health-related QoL and demographics were assessed by questionnaires. Disease and treatment characteristics were extracted from medical records.
Cancer-related fatigue was reported in 53% of the women treated for gynaecological cancers, with a higher proportion in the group of cervical cancer, followed by ovarian cancer. Younger participants reported fatigue more frequently than older participants. When adjusting for age, the type of cancer a woman experiences was shown to have little impact on her risk of experiencing fatigue. The participants with fatigue reported higher levels of anxiety and depression than participants without fatigue. There was a relationship between fatigue and quality of life as measured by SF-36 domains.
The findings underscore the importance of screening for fatigue, patient education and symptom management. This should be included in a standard procedure during treatment and follow-up. Both somatic and psychological aspects of fatigue should be emphasised.
The findings imply the need for health personnel to have focus on fatigue during the entire cancer trajectory of women after gynaecological cancers, as well as the need for screening, information, guidance and symptom management.
研究各类妇科癌症治疗女性中癌症相关疲劳的患病率,并针对这些癌症,评估疲劳与痛苦、健康相关生活质量、人口统计学及治疗特征之间的关系。
癌症治疗的进展提高了生存几率。因此,癌症幸存者的数量不断增加,且即使在治疗数年之后仍面临副作用。在该疾病的所有类型和阶段中,最常报告的副作用之一是癌症相关疲劳。
描述性横断面研究。
纳入120名参与一项干预研究的接受过妇科癌症治疗的女性。通过问卷调查评估疲劳、心理痛苦、健康相关生活质量和人口统计学情况。从医疗记录中提取疾病和治疗特征。
接受妇科癌症治疗的女性中有53%报告存在癌症相关疲劳,其中宫颈癌组比例更高,其次是卵巢癌。年轻参与者比年长参与者更频繁地报告疲劳。在调整年龄后,女性所患癌症类型对其经历疲劳的风险影响不大。有疲劳的参与者报告的焦虑和抑郁水平高于无疲劳的参与者。疲劳与SF-36量表所衡量的生活质量之间存在关联。
研究结果强调了筛查疲劳、患者教育和症状管理的重要性。这应纳入治疗和随访的标准程序中。应同时强调疲劳的躯体和心理方面。
研究结果表明,卫生人员在妇科癌症女性的整个癌症病程中都需要关注疲劳,同时也需要进行筛查、提供信息、给予指导和进行症状管理。